全文获取类型
收费全文 | 5281篇 |
免费 | 384篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 161篇 |
妇产科学 | 97篇 |
基础医学 | 1036篇 |
口腔科学 | 65篇 |
临床医学 | 424篇 |
内科学 | 1072篇 |
皮肤病学 | 149篇 |
神经病学 | 553篇 |
特种医学 | 141篇 |
外科学 | 447篇 |
综合类 | 15篇 |
一般理论 | 1篇 |
预防医学 | 460篇 |
眼科学 | 82篇 |
药学 | 349篇 |
中国医学 | 4篇 |
肿瘤学 | 590篇 |
出版年
2023年 | 28篇 |
2022年 | 50篇 |
2021年 | 87篇 |
2020年 | 55篇 |
2019年 | 120篇 |
2018年 | 127篇 |
2017年 | 82篇 |
2016年 | 104篇 |
2015年 | 137篇 |
2014年 | 164篇 |
2013年 | 245篇 |
2012年 | 389篇 |
2011年 | 407篇 |
2010年 | 201篇 |
2009年 | 236篇 |
2008年 | 375篇 |
2007年 | 393篇 |
2006年 | 396篇 |
2005年 | 378篇 |
2004年 | 412篇 |
2003年 | 343篇 |
2002年 | 329篇 |
2001年 | 47篇 |
2000年 | 37篇 |
1999年 | 55篇 |
1998年 | 80篇 |
1997年 | 46篇 |
1996年 | 48篇 |
1995年 | 57篇 |
1994年 | 36篇 |
1993年 | 29篇 |
1992年 | 15篇 |
1991年 | 23篇 |
1990年 | 16篇 |
1989年 | 15篇 |
1988年 | 6篇 |
1987年 | 8篇 |
1986年 | 10篇 |
1985年 | 8篇 |
1984年 | 9篇 |
1983年 | 10篇 |
1982年 | 9篇 |
1981年 | 11篇 |
1980年 | 9篇 |
1979年 | 6篇 |
1976年 | 3篇 |
1975年 | 3篇 |
1974年 | 5篇 |
1970年 | 2篇 |
1957年 | 2篇 |
排序方式: 共有5677条查询结果,搜索用时 15 毫秒
121.
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas 总被引:6,自引:1,他引:6
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Grange F Petrella T Beylot-Barry M Joly P D'Incan M Delaunay M Machet L Avril MF Dalac S Bernard P Carlotti A Esteve E Vergier B Dechelotte P Cassagnau E Courville P Saiag P Laroche L Bagot M Wechsler J 《Blood》2004,103(10):3662-3668
Bcl-2 protein expression has been associated with poor prognosis in patients with noncutaneous diffuse large B-cell lymphomas. In primary cutaneous large B-cell lymphomas, the location on the leg, the round-cell morphology defined as the predominance of centroblasts and immunoblasts over large centrocytes, and multiple skin lesions were identified as adverse prognostic factors. The prognostic value of bcl-2 protein expression has not been studied in large series of patients. We evaluated 80 primary cutaneous large B-cell lymphomas collected by the French Study Group on Cutaneous Lymphomas. The prognostic value of age, sex, number of lesions, cutaneous extent, location, serum lactate dehydrogenase (LDH) level, B symptoms, morphology, and bcl-2 protein expression was studied. The overall 5-year specific survival rate was 65%. In univariate analysis, advanced age, multiple skin lesions (n = 48), location on the leg (n = 25), round-cell morphology (n = 32), and bcl-2 expression (n = 39) were significantly related to death from lymphoma. In multivariate analysis, bcl-2 expression (P =.0003), multiple skin lesions (P =.004), and age remained independent prognostic factors. The 5-year specific survival rates in bcl-2-positive and bcl-2-negative patients were 41% and 89%, respectively (P <.0001). A new prognostic classification of primary cutaneous B-cell lymphoma should be based primarily on bcl-2 protein expression rather than the location of skin lesions. 相似文献
122.
Pascal Cohen Christian Pagnoux Alfred Mahr Jean‐Pierre Arène Luc Mouthon Véronique Le Guern Marie‐Hélène André Martine Gayraud David Jayne Daniel Blöckmans Jean‐franÇois Cordier Loïc Guillevin The French Vasculitis Study Group 《Arthritis care & research》2007,57(4):686-693
Objective
To compare long and short durations of adjunctive cyclophosphamide for the treatment of severe Churg‐Strauss syndrome (CSS).Methods
In this prospective multicenter therapeutic trial, 48 patients with CSS with at least 1 poor‐prognosis factor at baseline were treated with glucocorticoids and either 12 or 6 intravenous cyclophosphamide pulses.Results
At 8 years, complete remission rates and severe side effects of therapy were comparable for both groups. The overall difference in relapses was not significant between the 12‐pulse and the 6‐pulse regimens (P = 0.07), but when considering only the number of mild relapses this difference became statistically significant (P < 0.02). Although the total number of inclusions was not reached, the study was stopped prematurely in response to the superiority of the 12‐pulse regimen.Conclusion
We concluded that 12 cyclophosphamide pulses were better able to control severe CSS than a 6‐pulse regimen. The optimal duration of therapy remains to be determined. 相似文献123.
124.
Constantino S. Peña Volkan Tuncay James F. Benenati Alex Powell Ripal T. Gandhi Brian J. Schiro Martine van Alfen Barry T. Katzen 《Journal of vascular and interventional radiology : JVIR》2021,32(2):220-225.e2
PurposeTo evaluate the impact of a versatile flexible ceiling-mounted C-arm on active table and gantry repositioning during interventions and its effect on operator discomfort, system usability, and patient safety compared with a traditional ceiling-mounted system.Materials and MethodsThere were 100 IR procedures studied: 50 in a traditional IR system (standard group) and 50 with a novel multiaxis ceiling-mounted system (test group). FlexArm was capable of multiple gantry rotation points allowing increased access to the patient in addition to 236 cm of lateral x-ray detector travel. For each procedure, both the table and the gantry repositioning were measured. Patient safety, patient/equipment repositioning effort, and physical discomfort were evaluated through an operator survey.ResultsTable repositioning was reduced from 42 to 16 instances per procedure (P < .001) in the test group compared with the standard group. The operators perceived less table and gantry repositioning effort (P < .0001) and decreased risks of equipment collisions, displacement of vascular access, and dislodgment of tubes/lines with the test group (P < .0001). Operator discomfort was reduced for all body areas in the test group over the standard group (P < .0001).ConclusionsThe FlexArm system geometry enhances operator ergonomics, as there was a decrease need to move the table, leading to a perceived decrease in patient risk and decrease operator physical discomfort when compared to a traditional imaging system. 相似文献
125.
126.
127.
128.
129.
130.